These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31065329)
21. A Case of Lupus Nephritis Preceded by Minimal Change Disease and Membranous Glomerulonephritis. Zhang F; Jiang N; Munisamy Selvam KK; Li B; Wu Q; Wen S; Xu R; Liu S Am J Case Rep; 2023 Apr; 24():e938402. PubMed ID: 37005706 [TBL] [Abstract][Full Text] [Related]
22. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients. Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812 [TBL] [Abstract][Full Text] [Related]
23. Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients in Cape Town: a retrospective analysis. Mbuli L; Mapiye D; Okpechi I Pan Afr Med J; 2015; 22():365. PubMed ID: 27022425 [TBL] [Abstract][Full Text] [Related]
24. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis. Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273 [TBL] [Abstract][Full Text] [Related]
25. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142 [TBL] [Abstract][Full Text] [Related]
26. Lupus nephritis: An approach to diagnosis and treatment in South Africa. Okpechi IG; Ameh OI S Afr Med J; 2015 Dec; 105(12):1071-4. PubMed ID: 26933719 [TBL] [Abstract][Full Text] [Related]
27. Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center. Delfino J; Dos Santos TAFG; Skare TL Adv Rheumatol; 2020 Jan; 60(1):5. PubMed ID: 31900216 [TBL] [Abstract][Full Text] [Related]
28. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement. Hsieh YP; Wen YK; Chen ML Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964 [TBL] [Abstract][Full Text] [Related]
29. A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran. Pakfetrat M; Malekmakan L; Kamranpour M; Tadayon T Lupus; 2017 Sep; 26(10):1082-1088. PubMed ID: 28420065 [TBL] [Abstract][Full Text] [Related]
30. Clinical association between Kikuchi׳s disease and systemic lupus erythematosus: A systematic literature review. Sopeña B; Rivera A; Chamorro A; Freire M; Alende V; Seco E; González-Gay MA; González-Quintela A Semin Arthritis Rheum; 2017 Aug; 47(1):46-52. PubMed ID: 28233572 [TBL] [Abstract][Full Text] [Related]
31. Development of lupus nephritis in a patient with previous scleroderma renal crisis. McConville E; Smith D; Bélanger E; Ivory C Lupus; 2018 Sep; 27(10):1732-1734. PubMed ID: 30028255 [TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis. Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208 [TBL] [Abstract][Full Text] [Related]
33. Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus. Alkhatib MH; Kant S; Menez S; Lakhani L; Sperati CJ; Fine DM; Arend LJ; Atta MG J Nephrol; 2021 Dec; 34(6):1907-1913. PubMed ID: 33689148 [TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus. Kotzen ES; Roy S; Jain K Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722 [TBL] [Abstract][Full Text] [Related]
35. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the Clinical Implications among Five Different Nutritional Indices in Patients with Lupus Nephritis. Ahn SS; Yoo J; Jung SM; Song JJ; Park YB; Lee SW Nutrients; 2019 Jun; 11(7):. PubMed ID: 31252552 [TBL] [Abstract][Full Text] [Related]
37. Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients. Touzot M; Terrier CS; Faguer S; Masson I; François H; Couzi L; Hummel A; Quellard N; Touchard G; Jourde-Chiche N; Goujon JM; Daugas E; Medicine (Baltimore); 2017 Dec; 96(48):e9017. PubMed ID: 29310419 [TBL] [Abstract][Full Text] [Related]
38. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020 [TBL] [Abstract][Full Text] [Related]
39. Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes. Wenderfer SE; Chang JC; Goodwin Davies A; Luna IY; Scobell R; Sears C; Magella B; Mitsnefes M; Stotter BR; Dharnidharka VR; Nowicki KD; Dixon BP; Kelton M; Flynn JT; Gluck C; Kallash M; Smoyer WE; Knight A; Sule S; Razzaghi H; Bailey LC; Furth SL; Forrest CB; Denburg MR; Atkinson MA Clin J Am Soc Nephrol; 2022 Jan; 17(1):65-74. PubMed ID: 34732529 [TBL] [Abstract][Full Text] [Related]
40. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. Adhya Z; Borozdenkova S; Karim MY Nephrol Dial Transplant; 2011 Oct; 26(10):3273-80. PubMed ID: 21372259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]